Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern

Nephrol Dial Transplant. 2024 Apr 26;39(5):893-895. doi: 10.1093/ndt/gfae012.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunologic Factors / therapeutic use
  • Male
  • Middle Aged
  • Nephrosis, Lipoid* / drug therapy
  • Nephrosis, Lipoid* / pathology
  • Nephrotic Syndrome* / drug therapy
  • Rituximab* / therapeutic use

Substances

  • Immunologic Factors
  • Rituximab